Joseph Gilliam
President bij GLAUKOS CORPORATION
Vermogen: 10 M $ op 31-03-2024
Profiel
Joseph E.
Gilliam's current jobs include being a Director at Avedro, Inc. since 2019, a Director at Caris Life Sciences, LLC since 2021, and the President & Chief Operating Officer at Glaukos Corp.
since 2017.
Previously, he worked as a Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2001 to 2017.
He completed his undergraduate degree at Kelley School of Business in 1998.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GLAUKOS CORP
0.21% | 08-04-2024 | 101 845 ( 0.21% ) | 10 M $ | 31-03-2024 |
Actieve functies van Joseph Gilliam
Bedrijven | Functie | Begin |
---|---|---|
GLAUKOS CORPORATION | President | 01-04-2022 |
AVEDRO, INC. | Director/Board Member | 21-11-2019 |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Director/Board Member | 12-04-2021 |
Eerdere bekende functies van Joseph Gilliam
Bedrijven | Functie | Einde |
---|---|---|
JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01-05-2017 |
Opleiding van Joseph Gilliam
Kelley School of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
JPMORGAN CHASE & CO. | Finance |
GLAUKOS CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Avedro, Inc.
Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Health Services |